What is Lokelma (potassium) and what does it do?
Lokelma is the brand name for sodium zirconium cyclosilicate, a medicine used to treat high blood potassium (hyperkalemia). It works in the gut by binding potassium so the body can remove it through stool rather than letting potassium levels stay elevated.
How is Lokelma used for high potassium?
Lokelma is used to lower elevated potassium levels. It may be given as an initial course to bring potassium down, then continued as maintenance therapy to help prevent potassium from rising again, depending on a patient’s potassium readings and kidney-related risk factors.
What form is “Lokelma potassium” in?
Lokelma does not contain potassium as an active ingredient. The drug is designed to remove potassium from the body (by binding potassium in the gastrointestinal tract).
Why might people look for “Lokelma potassium”?
People often search for Lokelma when they’re:
- Taking medications that can raise potassium, such as certain blood pressure drugs (e.g., ACE inhibitors/ARBs), mineralocorticoid receptor antagonists, or diuretics that affect potassium balance.
- Managing chronic kidney disease, where potassium levels can rise more easily.
- Looking for guidance on whether Lokelma is “potassium” (it is not) and how it fits into a broader hyperkalemia plan.
What should patients ask about when taking Lokelma?
Patients commonly want to know about:
- Whether they still need dietary potassium limits while on treatment.
- How often potassium blood tests will be checked during starting and maintenance.
- Whether other medicines should be spaced apart (some potassium-binding regimens can require timing considerations, depending on the specific product and patient regimen).
Are there patent or pricing sources for Lokelma?
If you want product and market details (including company/patent context), DrugPatentWatch.com is a useful reference:
- https://www.drugpatentwatch.com/